OAR 325-015-0015
Termination of Participation


The Commission’s reporting program relies on voluntary reporting. However, the Commission is responsible for ensuring that those who choose to participate also comply with the standards established by the Commission.


Participation requirements include the reporting of all Reportable Adverse Events; fully completing Event Reports; creating and implementing acceptable action plans; and providing written disclosure to patients or families following a Reportable Serious Adverse Event.


If the Commission believes a Pharmacy Participant is not meeting its participation requirements, the Commission must provide the Pharmacy Participant with a written notice explaining why. The Pharmacy Participant will have 30 calendar days to respond and come into compliance.


The Commission may deny, suspend, or revoke a Pharmacy Participant’s status when the Commission finds that there has been a substantial failure to comply with the provisions of participation. Upon written notification by the Commission of revocation, suspension, or denial of a Pharmacy Participant enrollment in the Oregon Patient Safety Reporting Program, a Pharmacy Participant may request a hearing. Hearings will be held in accordance with ORS 183.310 (Definitions for chapter) to 183.470 (Orders in contested cases).

Source: Rule 325-015-0015 — Termination of Participation, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=325-015-0015.

Last Updated

Jun. 8, 2021

Rule 325-015-0015’s source at or​.us